Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib + an aromatase inhibitor|DRUG: Aromatase inhibitor
Sponsor: Pfizer